Use of poly diallyamine polymers
US7767229B1 · kind B1 · utility
51Cited by
5References
15Claims
0Family size
Inventors
Key dates
| Filing date | Nov 10, 2000 |
| Grant date | Aug 3, 2010 |
| Priority date | — |
| Expiry date | Apr 16, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G61/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A poly(diallylamine)polymer pharmaceutical composition or pharmaceutical derivate used to sequester bile acid and/or to reduce serum cholesterol levels. The polymer is derived from a monomer of formula Ia, where R6 is a bridging group of valency r, and r is an integer of 3 or greater to provide a cross linked polymer, and all diallyl nitrogen atoms are linked to at least two further diallyl nitrogen atoms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.